US starts vaccinating children under 5: 4 updates

On June 18, the CDC backed the FDA’s authorizations for Pfizer’s and Moderna’s vaccines for children under 5, offering protection against COVID-19 for about 19 million infants and preschoolers in the U.S.

Advertisement

Here are four things to know: 

1. More than 100 hospitals, pediatrician’s offices and pop-up clinics have 10 million doses of both vaccines and will inoculate children 5 and younger nationwide this week. 

2. Moderna’s two-dose, 25-microgram vaccine is for 6-month- to 5-year-olds. Pfizer’s three-shot, 3-microgram vaccine is for 6-month- to 4-year-olds. 

3. Pfizer’s vaccine has an 80 percent efficacy rate. The Moderna vaccine has a 51 percent efficacy rate for children 6 to 23 months old, and a 37 percent efficacy rate for 2- to 5-year-olds.

4. In clinical studies, both companies reported side effects comparable to reactions among older populations.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.